Pediatric Infectious Disease

Register      Login

VOLUME 4 , ISSUE 3 ( July-September, 2022 ) > List of Articles


The Efficacy and Safety of a Bacillus Probiotic Combination for the Treatment of Acute Diarrhea in Children: A Double-blind, Randomized, Placebo-controlled Multicentric Study

Ashish Ramchandra Dhongade, Sanjay Sudhakar Joshi, Suhas Venkatesh Kulkarni, Shashank S Jadhav, Neeta Nargundkar, Deepak Deshmukh, Anirudh Dilip Mehta

Keywords : Acute infective diarrhea, Antibiotic-associated diarrhea, Bacillus coagulans SC208, Bacillus subtilis HU58, Bristol stool scale

Citation Information : Dhongade AR, Joshi SS, Kulkarni SV, Jadhav SS, Nargundkar N, Deshmukh D, Mehta AD. The Efficacy and Safety of a Bacillus Probiotic Combination for the Treatment of Acute Diarrhea in Children: A Double-blind, Randomized, Placebo-controlled Multicentric Study. Pediatr Inf Dis 2022; 4 (3):86-91.

DOI: 10.5005/jp-journals-10081-1370

License: CC BY-NC 4.0

Published Online: 31-08-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Objective: Probiotics have been researched extensively over the past few years for the prevention and treatment of diarrhea in pediatric populations. In the present study, the efficacy and safety of probiotic Bacillus subtilis HU58 and probiotic Bacillus coagulans SC208 in combination were evaluated in children for the treatment of acute diarrhea. Materials and Methods: In this randomized, double-blind, parallel, placebo-controlled trial, 64 children with average age of 4.18 ± 3.0 years (mean ± standard deviation), out of which 32 children with antibiotic-associated diarrhea (AAD) and 32 children with acute infective diarrhea randomly received either syrup containing B. subtilis HU58 and B. coagulans SC208 probiotics or placebo syrup daily for a period of 7 days. Stool consistency, duration of diarrhea in days, and abdominal pain intensity during the treatment period, were assessed daily in all subjects for the improvement in clinical signs and symptoms. Also, an assessment of adverse events was done from the screening visit to the end of study visit. Result: A total of 32 subjects were screened and randomized in both cohort 1 and cohort 2. At the end of the study, that is, on day 7, B. subtilis HU58 + B. coagulans SC208 syrup-treated subjects in both cohorts showed significant improvement in stool consistency and duration of diarrhea over placebo syrup. No adverse events were observed in the study of both cohorts. Conclusion: This study's results conclude that B. subtilis HU58 and B. coagulans SC208 syrup improved the recovery and reduced the course of acute infectious diarrhea and AAD in children, with no reported adverse effects.

PDF Share
  1. Diarrheal Disease Factsheet. World Health Organization; 2017. [retrieved 2020 29 Oct 29].
  2. Radlovic N, Lekovic Z, Vuletic B, et al. Acute diarrhea in children. Srp Arh Celok Lek 2015;143(11–12):755–762. DOI: 10.2298/sarh1512755r
  3. Barr W, Smith A. Acute diarrhea. Am Fam Physician 2014;89(3):180–189.
  4. Giannelli FR. Antibiotic-associated diarrhea. JAAPA 2017;30(10):46–47. DOI: 10.1097/01.JAA.0000524721.01579.c9
  5. Barbut F, Meynard JL. Managing antibiotic associated diarrhea. BMJ 2002;324(7350):1345–1346. DOI: 10.1136/bmj.324.7350.1345
  6. Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 2011;45 Suppl:S149-S153. DOI: 10.1097/MCG.0b013e3182257e98
  7. Guarino A, Vecchio A, Canani R. Probiotics as prevention and treatment for diarrhea. Curr Opin Gastroenterol 2009;25(1):18–23. DOI: 10.1097/MOG.0b013e32831b4455
  8. Konuray G, Erginkaya Z. Potential use of Bacillus coagulans in the food industry. Foods 2018;7(6):92. DOI: 10.3390/foods7060092
  9. Mehta DS, De Souza A, Jadhav SS, et al. An open labeled, placebo controlled trial to evaluate the role of probiotics-Bacillus subtilis HU58 and Bacillus coagulans SC208 on antibiotic associated diarrhea in humans. Biomed J Sci Tech Res 2020;29(4):22679–22684. DOI: 10.26717/BJSTR.2020.29.004839
  10. Mahen M, Rizka A. The efficacy of probiotic in adults with acute infectious diarrhea. eJournal Kedokteran Indonesia 2017;5(1). DOI: 10.23886/ejki.5.6713.57-63
  11. EL Hage R, Hernandez-Sanabria E, de Wiele TV. Emerging trends in “smart probiotics”: functional consideration for the development of novel health and industrial applications. Front Microbiol 2017;8:1889. DOI: 10.3389/fmicb.2017.01889
  12. Sidhu M, van der Poorten D. The gut microbiome. Aust Fam Physician 2017;46(4):206–211.
  13. Dudek-Wicher RK, Junka A, Bartoszewicz M. The influence of antibiotics and dietary components on gut microbiota. Prz Gastroenterol 2018;13(2):85–92. 10.5114/pg.2018.76005
  14. Knoop KA, McDonald KG, Kulkarni DH, et al. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut 2016;65(7):1100–1109. DOI: 10.1136/gutjnl-2014-309059
  15. Tulstrup MV, Christensen EG, Carvalho V, et al. Antibiotic treatment affects intestinal permeability and gut microbial composition in Wistar rats dependent on antibiotic class. PLoS One 2015;10(12):e0144854. DOI: 10.1371/journal.pone.0144854
  16. Guidelines for Evaluation of Probiotics in Food. Report of a Joint FAO/WHO. Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada; 2002.
  17. Hawrelak JA, Whitten DL, Myers SP. Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhea: a systematic review. Digestion 2005;72(1):51–56. DOI: 10.1159/000087637
  18. D'souza AL, Rajkumar C, Cooke J, et al. Probiotic in prevention of antibiotic associated diarrhea: meta-analysis. BMJ 2002;324(7350):1361. DOI: 10.1136/bmj.324.7350.1361
  19. Sazawal S, Hiremath G, Dhingra U, et al. Efficacy of probiotics in prevention of acute diarrhea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006;6(6):374–382. DOI: 10.1016/S1473-3099(06)70495-9
  20. Bekkali N, Bongers ME, Berg MMVD, et al. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study. Nutr J 2007;6:17. DOI: 10.1186/1475-2891-6-17
  21. Ruszczynski M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhea in children. Aliment Pharmacol Ther 2008;28(1):154–161. DOI: 10.1111/j.1365-2036.2008.03714.x
  22. Allen SJ, Martinez EG, Gregorio GV, etal. Probiotics for treating acute infectious diarrhea. Cochrane Database Syst Rev 2010;10(11):CD003048. DOI: 10.1002/14651858.CD003048.pub3
  23. Cutting SM. Bacillus probiotics. Food Microbiol 2011;28(2):214–220. DOI: 10.1016/
  24. Hong HA, Khaneja R, Tam NMK, et al. Bacillus subtilis isolated from the human gastrointestinal tract. Res Microbiol 2009;160(2): 134–143. DOI: 10.1016/j.resmic.2008.11.002
  25. Hong HA, To E, Fakhry S, et al. Defining the natural habitat of Bacillus spore-formers. Res Microbiol 160(6):375–379. DOI: 10.1016/j.resmic.2009.06.006
  26. Marzorati M, Abbeele PVD, Bubeck SS, et al. Bacillus subtilis HU58 and Bacillus coagulans SC208 probiotics reduced the effects of antibiotic-induced gut microbiome dysbiosis in an M-SHIME® model. Microorganisms 2020;8(7):1028. DOI: 10.3390/microorganisms8071028
  27. Chandra RK. Effect of Lactobacillus on the incidence and severity of acute rotavirus diarrhea in infants. A prospective placebo-controlled double-blind study. Nutr Res 2002;22(1–2):65–69. DOI: 10.1016/S0271-5317(01)00367-0
  28. Wang CR, Jin J. Effect of Medilac-S on diarrhea caused by an imbalance of intestinal flora. J Med Forum 2006;27:74–75.
  29. Miller LE, Ibarra A, Ouwehand AC, et al. Normative values for stool frequency and form using Rome III diagnostic criteria for functional constipation in adults: systemic review with meta-analysis. Ann Gastroenterol 2017;30(2):161–167. DOI: 10.20524/aog.2016.0108
  30. Dound Y, Jadhav SS, Devale M, et al. The effect of probiotic Bacillus subtilis HU58 on immune function in healthy human. The Indian Practitioner 2017;70:15–20.
  31. Mehta DS, de Souza A, Jadhav SS, et al. A study of probiotic Bacillus subtilis HU58 for the management of antibiotic-associated diarrhea in adults. The Indian Practitioner 2017;73(4):22–28.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.